Tesetaxel

From WikiMD.org
Jump to navigation Jump to search

Tesetaxel

Tesetaxel (pronounced te-se-tax-el) is a novel, orally administered chemotherapy drug that belongs to the class of taxanes. It is currently under investigation for the treatment of various types of cancer, including breast cancer, gastric cancer, and non-small cell lung cancer.

Etymology

The name "Tesetaxel" is derived from the class of drugs it belongs to, the taxanes. The prefix "Tese-" is a unique identifier, while "-taxel" is a common suffix used for drugs in this class.

Mechanism of Action

Tesetaxel works by disrupting the normal function of microtubules, a component of the cell's skeleton. This disruption prevents cancer cells from dividing and growing, leading to their death.

Clinical Trials

Several clinical trials have been conducted to evaluate the safety and efficacy of Tesetaxel in various types of cancer. These trials have shown promising results, with Tesetaxel demonstrating significant anti-tumor activity.

Side Effects

Common side effects of Tesetaxel include nausea, vomiting, hair loss, and neutropenia, a condition characterized by low levels of neutrophils, a type of white blood cell.

Related Terms

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski